Bilgunay Ilkin Safa, MD Fellow. Division of Diabetes, Endocrinology and Metabolism. Research Fellow NIH 2. Contact. Email [email protected] Address 777 Preston Research …

Bilgunay Ilkin Safa. Vanderbilt University Medical Center. Verified email at vumc.org. Articles Cited by. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. Cited by. ... M …

2024年10月1日 · Our research focuses on the effects of GLP-1 receptor agonists and SGLT2 inhibitors on adipose tissue and systemic inflammation. I work closely with immune cells, …

ORCID record for Bilgunay Ilkin Safa. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.

In this review, we detail the systemic and tissue- or organ-specific anti-inflammatory effects of SGLT2 inhibitors using evidence from animal and human studies. We discuss the potential …

Written by Bilgunay Ilkin Safa, M.D. I was born and raised in Istanbul, Turkey, a city rich in history and culture. Growing up, my mother, a dedicated nurse, was my first inspiration.

In this review, we detail the systemic and tissue- or organ-specific anti-inflammatory effects of SGLT2 inhibitors using evidence from animal and human studies. We discuss the potential …

Bilgunay Ilkin Safa MD Fellow. Diabetes, Endocrinology and Metabolism. Katlyn Sawyer Fellow. Diabetes, Endocrinology and Metabolism. Elizabeth Stivison Fellow. Diabetes, Endocrinology …

2023年4月22日 · In rodent models, SGLT2 inhibition decreases proin flammatory mediators including interleukin (IL)-6, C-reactive protein (CRP), monocyte chemoattractant protein-1 …